Melanoma

Lancet

Volumn 347, Issue 9004, 1996, Pages 803-806

  Rivers, Jason K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; DACARBAZINE; MELPHALAN;

CANCER PREVENTION; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; MELANOMA; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SIDE EFFECT;

EID: 0029990190     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(96)90873-9     Document Type: Article

References (39)

1. Armstrong BK, Cricker A. Cutaneous melanoma. Cancer Surveys 1994; 19: 219-39.
2. National Cancer Institute of Canada. Canadian cancer statistics 1995. Toronto: NCI of Canada, 1995.
3. International Agency for Research on Cancer. Ultraviolet radiation: IARC monographs on the evaluation of carcinogenic risks to humans vol 55. Lyon: IARC, 1992.
4. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.
5. Whiteman D, Green A. Melanoma and sunburn. Cancer Causes Control 1994; 5: 564-72.
6. Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma. Eur J Cancer 1994; 30A: 1647-54.
7. Pion IA, Rigel DS, Garfinkel L, Silverman MK, Kopf AW. Occupation and the risk of malignant melanoma. Cancer 1995; 75: 637-44.
8. Kirkpatrick CS. Epidemiology of diet and melanoma incidence: a brief review. In: Gallagher RP, Elwood JM, eds. Epidemiological aspects of cutaneous malignant melanoma. Boston: Kluwer, 1994: 243-51.
9. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Current concepts: melanoma in children. N Engl J Med 1995; 332: 656-62.
10. Williams ML, Sagebiel RW. Melanoma risk factors and atypical moles. West J Med 1994; 160: 343-50.
11. Marghoob AA, Slade J, Salopek TG, Kopf AW, Bart RS, Rigel DS. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Cancer 1995; 75: 707-14.
12. Garbe C, Buttner P, Weiss J, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatology Society. J Invest Dermatol 1994; 102: 695-99.
13. Rigel DS, Rivers JK, Kopf AW, et al. Dysplastic nevi: markers of increased risk for melanoma. Cancer 1989; 63: 386-89.
14. Goldstein AM, Fraser MC, Clark WH Jr, Tucker MA. Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi. J Natl Cancer Inst 1994; 86: 1385-90.
15. Bale SJ, Dracopoli NC, Tucker MA. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med 1989; 320: 1367-72.
16. Cannon-Albright LA, Goldar DE, Meyer LJ, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 1992; 258: 1148-52.
17. Goldstein AM, Dracopoli NC, Engelstein M, Fraser MC, Clark WH Jr, Tucker MA. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity. Am J Hum Genet 1994; 54: 489-96.
18. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-40.
19. Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ. Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol 1990; 126: 763-66.
20. Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RAC. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 1994; 130: 48-50.
21. Avril MF, Cascinelli N, Cristofolini M, MacKie RM, Sober AJ. Clinical diagnosis of melanoma: WHO melanoma publications no 3. Milan: WHO, 1994.
22. Binder M, Schwarz M, Winkler A, et al. Epiluminesence microscopy: a useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995; 131: 286-91.
23. Hall PN, Claridge E, Morris Smith JD. Computer screening for early detection of melanoma: is there a future? Br J Dermatol 1995; 132: 325-38.
24. Green A, Martin N, Pfitzner J, O'Rourke M, Knight N. Computer image analysis in the diagnosis of melanoma. J Am Acad Dermatol 1994; 31: 958-64.
25. Voigt H, Classen R. Topodermatographic image analysis for melanoma screening and the quantitative assessment of tumor dimension parameters of the skin. Cancer 1995; 75: 981-88.
26. Rivers JK, Ho VC. Malignant melanoma: who shall live and who shall die? Arch Dermatol 1992; 128: 537-42.
27. Hughes DG, Gillespie JE, Goulding P. Case report: diagnosis of metastatic leptomeningeal melanoma by contrast enhanced MRI. Clin Radiol 1992; 46: 290-91.
28. Gritters LS, Francis IR, Zazadny KR. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose in the imaging of malignant melanoma. J Nucl Med 1993; 34: 1420-27.
29. Johnson TM, Smith JW II, Nelson BR, Chang A. Current therapy for cutaneous melanoma. J Am Acad Dermatol 1995; 32: 689-707.
30. Barth A, Morton DL. The role of adjuvant therapy in melanoma management. Cancer 1995; 75: 726-34.
31. Krementz ET, Carter RD, Sutherland CM, Muchmore JH, Ryan RF, Creech O Jr. Regional chemotherapy for melanoma: a 35-year experience. Ann Surg 1994; 220: 520-35.
32. Ho RCS. Medical management of stage IV malignant melanoma. Cancer 1995; 75: 735-41.
33. Kirkwood JM. Systemic therapy of melanoma. Curr Opin Oncol 1994; 6: 204-11.
34. Coates AS, Ingvar CI, Petersen-Schaefer K, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991. J Am Coll Surg 1995; 180: 402-09.
35. Nabel GJ, Nabel EG, Yang Z, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci 1993; 90: 11307-11.
36. Marks R. Skin cancer control in Australia: the balance between primary prevention and early detection. Arch Dermatol 1995; 131: 474-78.
37. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992; 304: 1012-15.
38. Melia J, Cooper EJ, Frost T, et al. Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma I: work-load and referral patterns. Br J Dermatol 1995; 132: 405-13.
39. Wender RC. Barriers to effective skin cancer detection. Cancer 1995; 75: 691-98.